Home » Topics » Regulatory

Regulatory
RSS

Ebixa receives European approval for moderate Alzheimer's disease

Oct. 14, 2005

Japan approves fluvoxamine maleate for social anxiety disorder

Oct. 14, 2005

Remicade approved in E.U. for moderate to severe plaque psoriasis

Oct. 7, 2005

European approval for Vasovist for magnetic resonance angiography

Oct. 5, 2005

GSK's Zefix approved in Japan for HBV-associated cirrhosis

Sep. 26, 2005

Remicade now approved in U.S. for ulcerative colitis

Sep. 20, 2005

Increlex approved for short stature caused by severe primary IGF-1 deficiency

Sep. 1, 2005

Actoplus Met approved for type 2 diabetes

Aug. 31, 2005

Taxotere approved for endometrial cancer in Japan

Aug. 24, 2005

Singulair approved for symptoms of perennial allergic rhinitis

Aug. 23, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.